Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 20/20 | 0.66 |
| ▸ | PTGS1 | P23219 | 8/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MT-CO1 | P00395 | 1/20 | 0.49 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974299 | 0.88 | PTGS2 (0.66) | PTGS2PTGS1KDM4EMT-CO1MT-CO2 | |
| SCHEMBL8974279 | 0.86 | PTGS2 (0.55) | PTGS2PTGS1 | |
| SCHEMBL8974066 | 0.86 | PTGS2 (0.64) | PTGS2PTGS1KDM4EMT-CO1MT-CO2 | |
| SCHEMBL8974257 | 0.86 | PTGS2 (0.50) | PTGS2PTGS1 | |
| SCHEMBL8974069 | 0.86 | PTGS2 (0.50) | PTGS2PTGS1 | |
| SCHEMBL8974351 | 0.84 | PTGS2 (0.57) | PTGS2PTGS1 | |
| SCHEMBL8974331 | 0.84 | PTGS2 (0.54) | PTGS2PTGS1 | |
| SCHEMBL8973837 | 0.83 | PTGS2 (0.47) | PTGS2PTGS1 | |
| SCHEMBL8974089 | 0.83 | PTGS2 (0.46) | PTGS2PTGS1CYP3A4CYP2C9 | |
| SCHEMBL851339 | 0.82 | PTGS2 (0.71) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995030656-A1 | SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-11-16 | — | — | WO | claimed |
| WO-1995030656-A1 | SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-11-16 | — | — | WO | disclosed |
| US-5418254-A | Side effect reduction | G. D. SEARLE & CO. (US) | 1995-05-23 | — | — | US | disclosed |